Peter Maag
North America, California, United States
Description
Peter Maag is the current Chief Executive Officer of Kyverna Therapeutics. He previously worked at CareDx as a Chairman of the Board and Chi...
Investor Profile
Peter Maag has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Debt Financing, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology.
Stage Focus
- Debt Financing (50%)
- Series A (50%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
